Small Cap Pharma Stock Rises Nearly 6% After Promoter Increases Stake To 35.18%

The shares of Bajaj Healthcare Ltd. on Friday rose nearly 6% to hit a 52-week high at Rs 474 apiece on the BSE. This comes after Mr Sajankumar Rameshwarlal Bajaj increased stake by 0.2% to 35.18% with the purchase of 56,000 shares on Sept 21, 2023.

Equity share capital/total voting capital of the TC before the said acquisition - 2,75,98,400 Equity Shares of Rs. 05/- each aggregating to Rs. 13,79,92,000/-

Equity share capital/total voting capital of the TC after the said acquisition - 2,75,98,400 Equity Shares of Rs. 05/- each aggregating to Rs. 13,79,92,000/-

Total diluted share/total voting capital of the TC after the said acquisition - 2,75,98,400 Equity Shares of Rs. 05/- each aggregating to Rs. 13,79,92,000/-

Bajaj Healthcare's shares on Friday closed 5.71% higher at Rs 464.90 apiece on the BSE. The stock zoomed 12.36% in 1 week. It zoomed 45.74% in the past one month. It gained 26.37% in 1 year. It has given 116.71% positive return in 3 years, and 348.10% positive return in 5 years.

The stock hit 52-week high at Rs 474 apiece and 52-week low at Rs 245.05 apiece on the BSE. It has a market cap of Rs 1,283.05 Crore.

Bajaj Healthcare Ltd. is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare Ltd. have metamorphosed into Specialty Company and focused on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.